ipafricept (OMP-54F28) - Mereo Biopharma
OncoMed: BIO CEO & Investor Conference (OncoMed) - Feb 12, 2016 - Anticipated data from P1b trials in HCC (NCT02069145), ovarian cancer (NCT02092363) and pancreatic cancer (NCT02050178) in 2016 
Anticipated P1 data • Hepatocellular Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer
https://www.veracast.com/bio/ceoinvestor2016/main/events/1111_oncome/pdf/OncoMed_Pharmaceuticals__Inc._(NASDAQ__OMED).pdf
 
Feb 12, 2016
 
.
 
011c9aa2-0073-45a0-9ad9-73e150eff04c.jpg